Under the venture, called SharedClarity, the member organizations will conduct independent studies on the long-term effectiveness of medical devices implanted in patients, such as stents, defibrillators, pacemakers, knee and hip implants and heart valves. Physicians from each health system will oversee the medical device studies, which will use data from member hospitals and claims information from UnitedHealthcare.
SharedClarity will use their findings to choose the best devices for patients and negotiate affordable purchasing agreements with device manufacturers, according to the news release. This venture is unique in that its studies will not be funded by manufacturers, according to the release.
SharedClarity plans to add health system members in the future.
More Articles on Hospital Quality:
Lowering Readmission Rates Through Retail Clinic Partnerships
Study: Multistate, Hospital-Based QI Programs Can Reduce Early Elective Deliveries
A 3-Phase Approach to Meet Healthcare Triple Aim: 13 Ethical Considerations & Recommendations
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.